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Studies on the chaperone protein α-hemoglobin stabilizing protein (AHSP) reveal that abundant AHSP in erythroid cells en-
hance the cells’ tolerance to oxidative stress imposed by excess α-hemoglobin in pathological conditions. However, the poten-
tial intracellular modulation of AHSP expression itself in response to oxidative stress is still unknown. The present study ex-
amined the effect and molecular mechanism of STAT3, an oxidative regulator, on the expression of AHSP. AHSP expression 
increased in K562 cells upon cytokine IL-6-induced STAT3 activation and decreased in STAT3 knock-down K562 cells. Reg-
ulation of AHSP in oxidative circumstance was then examined in α-globin-overloaded K562 cells, and real-time PCR showed 
strengthened expression of both AHSP and STAT3. ChIP analysis showed binding of STAT3 to AHSP promoter and binding 
was significantly augmented with IL6 stimulation and upon α-globin overexpression. Dual luciferase reporter assays of the 
wildtype and mutated SB3 element, an IL-6RE site, in the AHSP promoter in K562 cells highlighted the direct regulatory ef-
fect of STAT3 on AHSP gene. Finally, direct binding of STAT3 to SB3 site of AHSP promoter was confirmed with EMSA as-
says. Our work reveals an adaptive AHSP regulation mediated by the redox-sensitive STAT3 signaling pathway, and provides 
clues to the therapeutic strategy for AHSP enhancement. 
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Unbalanced globin chain synthesis exposes and sensitizes 
erythroid cells to oxidative stress. The newly defined 
α-hemoglobin stabilizing protein (AHSP) is necessary for 
free α-globin stabilization and hemoglobin tetramer assem-
bly [1,2], which guards against the threat imposed by free 
α-Hb. The interaction between AHSP and α-Hb converts the 
latter into a non-reactive, hexacoordinate ferric form and 
prevents its damaging effects as a pro-oxidant in vivo, un-
derlying the protective role of AHSP in the redox equilib-
rium of erythroid cells [3,4]. However, how AHSP itself is 
regulated under oxidative stress has been largely unknown.  
As critical signaling molecules under oxidative circum-
stances, reactive oxygen species (ROS) mediate distinct 
responses to oxidative stress through various pathways [5,6]. 
Signal transducers and activators of transcription (STAT) 
proteins are a group of important redox regulated effectors 
[7] that play important roles in regulating hematopoietic 
homeostasis [8]. STATs can be activated by ROS produc-
tion in response to the stimulation of cytokines or growth 
factors, during which STATs are recruited to their cognate 
receptors and phosphorylated at distinct tyrosine residues by 
the Janus family of kinases (JAKs) or Src kinases. Activated 
STATs then homo- or heterodimerize and translocate to the 
nucleus, initiating a cytoprotective process via modulating 
the expression of a panel of antioxidant genes or apoptotic 
genes, and participating in the regulation of cell survival, 
proliferation and maturation [9,10]. STAT3 is a major 
member of the STATs and is phosphorylated at Tyr705 and 
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Ser727 sites upon activation [11]. Constitutive STAT3 
phosphorylation exhibits oncogenic properties in promoting 
cell survival [12], and IL6 (interleukin 6)-gp130-STAT3- 
dependent gene activations have been demonstrated to con-
fer cyto-protection in distinct tissues [13,14]. 
In this report, we identified the AHSP gene as a STAT3 
target. Overloading -globins in K562 cells activates 
STAT3 and promotes AHSP gene expression. Multiple 
STAT3 binding sites were detected in the AHSP promoter, 
among which the SB3 site constitutes a key STAT3 regu-
lating element bordered by a Nrf2/ARE element. Mutation 
of the consensus cAMP responsive element (CRE) within 
the Nrf2/ARE element of the SB3 site dramatically de-
creased STAT3 transactivity on the AHSP promoter and 
abolished direct binding of STAT3 to the SB3 site. 
1  Materials and methods 
1.1  Cell culture and drug treatment 
Recombinant IL-6 (SRP3096) was purchased from Sigma- 
Aldrich (USA). For IL-6 stimulation, human chronic mye-
logenous leukemia K562 cells were collected and resus-
pended in serum free RPMI 1640 medium and treated with 
IL-6 (100 ng mL1) for 2 h. The human α-globin (HBA) 
over-expressing K562 stable line was cultured in RPMI 
1640 medium containing 10% fetal bovine serum, and hu-
man embryonic kidney 293T cells were maintained in Dul-
becco’s modified Eagle’s medium (high sugar) supple-
mented with 10% fetal bovine serum. 
1.2  Plasmid construction and transfection  
For generation of over-expression plasmids, the coding se-
quences of STAT3 and α-globin were cloned into 
pcDNA3.1() and pcDNA3.1(+) respectively. STAT3 was 
knocked down using hairpin RNA directed against the se-
quence 5′-GCGTCCAGTTCACTACTAA-3′, and the oli-
gonucleotides encoding shRNAs were ligated into an 
RNAi-ready pSIREN-RetroQ vector (Clontech, USA). The 
resulting STAT3 knock-down K562 cells were generated  
by retrovirus-mediated RNAi. The pRetroQ-siGFP (5′- 
GCAAGCTGACCCTGAAGTT-3′) vector was used as 
control. The HBA stable line (HBA-K562) and control cells 
were obtained by transfecting K562 cells with pCDNA3.1- 
HBA-myc and empty vector respectively, using Lipofec-
tamine 2000 (Invitrogen, USA). 
1.3  RNA extraction and real-time qRT-PCR 
Total RNA was extracted from differentially treated K562 
cells using Trizol (Invitrogen) according to the manufactur-
er’s instructions. First-strand cDNA was synthesized with 
M-MLV Reverse Transcriptase and random primer (New 
England Biolabs, USA). Real-time qPCR experiments were 
performed using the iQTM5 Real-Time PCR Detection 
System (Bio-Rad, USA) and SYBRGreen PCR Mix 
(TaKaRa, Japan). Primer pairs were as follows: AHSP am-
plication sense 5′-TGATCCTCTCGTCTGAAGAAGAC-3′ 
and antisense 5′-GCTGCCTGTAATAGTTGATGTAGA- 
AGT-3′; and STAT3 amplification: sense 5′-ACCTGCA- 
GCAATACCATTGAC-3′ and antisense 5′-AAGGTGAG- 
GGACTCAAACTGC-3′. AHSP and STAT3 expression lev-
els were quantified by normalizing against the internal con-
trol β-actin (sense 5′-GGACATCCGCAAAGACCTGTAC- 
3′ and antisense 5′-AGGAGGAGCAATGATCTTGATC- 
TT-3′) using the delta Ct method. 
1.4  Western blotting  
The STAT3 knock-down k562 cells were collected and 
lysed in RIPA buffer (NP-40 0.1%, NaCl 150 µmol L1, 
Tris-Cl 10 mmol L1, NaF 10 mmol L1, EDTA 2 mmol L1, 
DTT 100 µg mL1, PMSF 100 µg mL1 and Protease Inhib-
itor Cocktail, pH 8.0). Samples were quantified with a 
Pierce BCA protein assay kit, separated on a 15% 
SDS-PAGE gel and transferred to PVDF membranes. The 
membranes were then incubated overnight with monoclonal 
anti-STAT3 (D372G), anti-phospho-STAT3 (Tyr705) from 
Cell Signaling Technology (USA) or polyclonal an-
ti-GAPDH (FL-335) from Santa Cruz Biotechnology (USA), 
followed by incubation with corresponding secondary anti-
bodies for approximately 1–2 h at room temperature. The 
HBA-K562 stable line was identified with anti-c-Myc 
(9E10) monoclonal antibodies from Santa Cruz Biotech-
nology; anti-actin (AC-15) was obtained from Sigma. Bands 
were visualized with the ECL chemiluminescence kit (Vig-
orous, China). Human AHSP anti-serum was noncommer-
cial and generously provided by Dr. Weiss (Children’s 
Hospital of Philadelphia, USA). 
1.5  Reporter plasmid construction and luciferase re-
porter assay  
The AHSP promoter reporter plasmid (AHSP-Luc) was 
constructed by PCR amplification of the 1.1 kilobase region 
(912 to +254 bp) surrounding AHSP gene transcriptional 
start site and inserting the PCR product into the MluI/XhoI 
sites of pGL3-Basic vector (Promega, USA). SB3 reporter 
plasmids (SB3-Luc or SB3-mut) were constructed by an-
nealing synthesized DNA oligos containing the wild type or 
mutant STAT3 binding site (95 to 36 bp) with flanking 
MluI/XhoI sites, and inserting the resulting double-strand 
DNA into the pGL3-Enhancer vector (Promega). HEK293T 
cells were transfected at 50% confluence using VigoFect 
according to the manufacturer’s instructions (Vigorous). 
Cells were harvested 48 h later. Luciferase activity was 
measured with the Dual Luciferase Reporter Assay System 
Kit (Promega) and detected in a LB960 Microplate Lumi-
nometer (Berthold, Germany). Data were collected in at 
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least three separate experiments. The statistical significance 
test was used to analyze the results. 
1.6  Chromatin immunoprecipitation 
Chromatin immunoprecipitation (ChIP) analysis of control, 
IL-6 treated and α-globin-overloaded K562 cells was per-
formed as previously described with minor modifications 
[15]. The precleared cell lysates were immunoprecipitated 
individually with 4 µg of anti-STAT3 (D372G), anti-  
phospho-STAT3 (Tyr705), anti-phospho-STAT3 (Ser727) 
primary antibodies (Cell Signaling Technology) or 10 µL (4 
µg) normal rabbit IgG (Santa Cruz). Precipitated DNA was 
dissolved in 100 µL ddH2O and analyzed by real-time qPCR 
using the iQTM5 Real-Time PCR Detection System 
(Bio-rad) and SYBRGreen PCR Mix (TaKaRa) or by 
semi-quantitative PCR. PCR primers are listed in Table 1. 
The Y-axis of the quantitative ChIP results is shown as rela-
tive enrichment of immunoprecipitated DNA to input. The 
5′-UTR of the gamma-globin gene was used as a positive 
control for STAT3 binding [16] and the promoter of the 
brain-specific necdin gene served as a negative control. 
1.7  Electrophoretic mobility shift assay 
Nuclear extracts were prepared from electrophile tBHQ 
(tert-butylhydroquinone) treated (20 µmol L1, 6 h) and 
control K562 cells as described [17]. EMSA analysis was 
performed using a LightShift Chemiluminescent EMSA Kit 
(Pierce, USA) according to the manufacturer’s instructions. 
Each reaction contained 20 µL volume including 8 µg nu-
clear extract and 20 nmol L1 labeled and annealed SB3 
probe (forward: biotin-5′-TCTCCTCCCTAGAATGACCT- 
ATCACCCTCCTTCAGGACCT-3′ and reverse: biotin- 
5′-AGGTCCTGAAGGAGGGTGATAGGTCATTCTAGG
GAGGAGA-3′) or mutant SB3 probe in which the muta-
tions are shown in lowercase letters (forward: biotin-  
5′-TCTCCTCCCTAGAagacCCTAcagCCCTCCTTCAGG- 
ACCT-3′ and reverse: biotin-5′-AGGTCCTGAAGGAG- 
GGctgTAGTgtcTTCTAGGGAGGAGA-3′). Nrf2 (4 µg) 
antibody was used in supershift assays, and 150-fold molar 
excess unlabeled IL-6RE probes (repeated TTCTGGGAA) 
containing canonic STAT3 binding sequence were 
pre-incubated in competition experiments. Reaction mix-
tures were fractionated on non-denaturing 6% polyacryla-
mide gels and transferred to a nylon membrane. The DNA 
was cross-linked to the membrane by UV-light at 150 mJ 
cm2 and the membrane was exposed to X-ray film and de-
veloped.  
2  Results 
2.1  AHSP is a target gene of STAT3 
STAT3 is one of the key regulators in the ability of hema-
topoietic cells to cope with oxidative stress [18]. To exam-
ine whether the α-globin chaperone AHSP is a target gene 
of STAT3 signaling in redox equilibrium of erythroid cells, 
we first used cytokine IL-6 as a STAT3 signaling inducer to 
treat the chronic myelogenous leukemia K562 cell line and 
detected enhanced AHSP expression after IL-6 treatment 
(Figure 1A and B). Conversely, knockdown of STAT3 in 
K562 cells with pSIREN-RetroQ retrovirus expressing short 
hairpin RNA against STAT3 led to decreased STAT3 as 
well as AHSP expression at both the mRNA level (Figure 
1C) and protein level (Figure 1D). Simultaneous up-   
regulation of STAT3 and AHSP genes were observed in 
K562 cells overloaded with α-globin (HBA-K562), which 
to some degree mimics the pathologically oxidative envi-
ronment of β-thalassemia (Figure 1E and F). These results 
collectively suggest that STAT3 is a regulator of AHSP 
gene expression, and implied that AHSP could be targeted 
by STAT3 in response to oxidative stress in erythroid cells.  
2.2  STAT3 binds to and activates AHSP promoter   
To further explore the regulatory mechanisms through 
which STAT3 may regulate AHSP expression, we investi-
gated the direct occupancy of STAT3 at the promoter of 
AHSP in K562 cells. STAT family proteins generally rec-
ognize a consensus DNA binding motif of TTCC (C or G) 
GGAA (or generically TTN5AA) [19]. Three putative 
STAT3 binding sites (SB), named SB1 to SB3, were pre-
dicted in the AHSP promoter (Figure 2A). ChIP analyses 
were performed to detect the binding of total STAT3 and its 
active forms, Tyr705 and Ser727 phosphorylated STAT3 
(pSTAT3-Tyr705 and pSTAT3-Ser727), at the putative 
binding sites. In untreated K562 cells, weak binding of 
STAT3 was detected at the SB1 site, and no binding of ei-
ther active form of STAT3 was detected. After 2 h treat-
ment with IL-6 (100 ng mL1), which activates the STAT3 
signaling pathway, intense binding of STAT3 was found at 
SB2 and the pSTAT3-Tyr705 signal became detectable at 
both SB2 and SB3 sites, while the signal for 
pSTAT3-Ser727 remained undetectable (Figure 2B). We 
next examined STAT3 binding status in α-globin-    
overloaded K562 cells. Similar to IL6-induced cells, 
STAT3 was observed to bind to SB2, while pSTAT3- 
Tyr705was specifically detected at the SB3 site (Figure 2C). 
No obvious pSTAT3-Ser727 signal was detected. 
To examine the transactivity of STAT3 on the AHSP 
promoter, which contains SB2 and SB3, we established a 
luciferase reporter construct by inserting the AHSP promot-
er sequence (912 to +254 bp) into the pGL3-basic vector 
(AHSP-Luc). The empty pGL3-basic vector was used as a 
negative control. Co-expression of STAT3 in HEK293T cells 
stimulated the activity of AHSP-Luc by nearly 6-fold com-
pared with ASHP-Luc alone, suggesting that STAT3 regu-
lates AHSP expression by targeting its promoter (Figure 2D). 
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Figure 1  AHSP is a target gene of STAT3. A, Real-time PCR analysis of AHSP expression in IL6-induced (100 ng mL1, 2 h) and control K562 cells. B, 
Western blot analysis of AHSP and p-STAT3(Y705) levels in IL6-induced (100 ng mL1, 2 h) and control K562 cells. Real-time PCR (C) and Western blot 
(D) analysis of AHSP and STAT3 expression in shSTAT3 and control shGFP K562 cells 72 h after the retrovirus delivery. Untreated K562 cells were used 
as a negative control in Western blot analysis. E, Western blot analysis of α-globin-overloaded and control K562 stable lines. Myc-tagged α-globin was 
identified with anti-myc antibody. F, Real-time PCR analysis of AHSP and STAT3 expression in α-globin-overloaded and control K562 stable lines. *, 
P<0.05; **, P<0.01. 
 
Figure 2  STAT3 binds directly to AHSP promoter region in IL6-stimulated and α-globin-overloaded K562 cells. A, The three putative STAT3 binding 
sites in the AHSP gene promoter. B, Quantitative ChIP analysis of total STAT3 and p-STAT3 occupancy at putative sites in the AHSP promoter in 
IL6-induced (100 ng mL1, 2 h) and untreated K562 cells. C, Semi-quantitative ChIP analysis of total STAT3 and p-STAT3 occupancies at putative sites in 
the AHSP promoter in α-globin-overloaded K562 cells. D, Dual luciferase reporter analysis of STAT3 transactivation of AHSP promoter in HEK293T cells. 
*, P<0.05; **, P<0.01. 
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2.3  The SB3 element is a critical site for STAT3 bind-
ing and activation of AHSP promoter 
In both IL6-induced and α-globin-overloaded K562 cells, 
pSTAT3-Tyr705, the active form of STAT3 was found to 
strongly bind to the SB3 element (167 to 21 bp) upstream 
of the AHSP transcriptional initiation site. Analysis of the 
SB3 sequence revealed an atypical STAT3/IL-6RE binding 
site TCCCTAGAA bordered by a cAMP responsive ele-
ment (CRE)-like element within an atypical Nrf2/ARE site 
(Figure 3A). The CRE element has been shown to be nec-
essary for STAT3 function in regulating JunB [20] and 
STAT3 itself [21]. The luciferase activity of the SB3 re-
porter (SB3-Luc) was induced by approximately 6-fold with 
stimulation of STAT3 compared with SB3-Luc alone (Fig-
ure 3B). Mutation of TGAC...TCA in the CRE element to 
GACC…CAG almost completely offset the STAT3 effect 
(Figure 3B), suggesting the dependency of STAT3 activity 
on the proximal CRE element.  
Direct binding of STAT3 to SB3 element was deter-
mined in EMSA analysis (Figure 3C). Two shifted bands 
were observed with a probe containing the SB3 element, 
both of which were strengthened with nuclear extracts from  
 
 
Figure 3  The SB3 element is directly targeted and activated by STAT3. A, Sequence analysis of SB3 in the AHSP proximal promoter. An atypical STAT3 
binding site (black capitals) juxtaposed to a putative Nrf2 binding site (underlined) is found in the −61 to −75 bp region of SB3. Consensus CRE-like ele-
ment (gray box) is shown embedded in the putative Nrf2 binding element. B, Dual luciferase reporter analysis of STAT3 trans-activity on SB3 element in 
HEK 293T cells. Mutation of the consensus CRE-like element (labeled with stars) eliminated STAT3 transactivation via the SB3 element. **, P<0.01. C, 
EMSA analysis of the SB3 probe with nuclear extracts from tBHQ treated and control K562 cells. Note that the lower band was specifically supershifted by 
Nrf2 antibody. Mutation of the CRE-like element had no effect on the lower band, but resulted in the disappearance of the top band, which was completely 
competed by 150-fold molar excess of the cold IL-6RE probe. 
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tBHQ-treated K562 cells. The lower band was identified as 
a Nrf2 shift as it was specifically supershifted by Nrf2 anti-
body. Introduction of the CRE mutation into the SB3 probe 
resulted in the alleviation of the top shifted band, addition 
of 150-fold molar excess of cold IL6-RE probe completely 
competed the shift band away. These observations con-
firmed the binding of STAT3 on the top band and indicated 
that the CRE mutation disrupted the binding of STAT3 to 
the SB3 element.     
3  Discussion  
AHSP is a unique chaperone molecule involved in hemo-
globin subunit stabilization and assembly. Lineage specific 
AHSP expression, like that of many other erythroid specific 
genes, has been attributed to the master erythroid transcrip-
tion factors including GATA1, EKLF, and NFE2P45 
[22,23]. In this study, we show that AHSP expression is 
directly modulated by STAT3 signaling. We characterized 
the binding pattern of STAT3 to the AHSP promoter upon 
IL6 induction and α-globin overloading in K562 cells. Fur-
thermore, the CRE element proximal to the STAT3 con-
sensus sequence in the SB3 site of the AHSP promoter was 
found critical for the binding and activity of STAT3. Our 
work provides the first evidence for the dynamic regulation 
of AHSP expression by a cell signaling pathway and implies 
that AHSP may be an active responder to oxidative stress. 
Cytokine IL-6, in combination with multiple factors, is 
reported to act in the early stage of erythropoiesis [24]. 
STAT3 is a well-known downstream effector of IL-6 sig-
naling in acute-phase response regulation [25]. It is also 
shown to be required for erythropoietin receptor dependent 
regulation of red blood cell development [26]. A recent 
study claimed that cell-targeted deletion of the STAT3 gene 
in hematopoietic stem cells/hematopoietic progenitor cells 
results in excessive ROS production and shortened cell life 
span [27]. In addition, significant upregulation of STAT3 is 
found to accompany extramedullary stress erythropoiesis 
[28], and constitutive STAT3 activation by IL6 has been 
found in polycythemia vera patients [29]. We show that a  
2 h induction with IL-6 stimulates the binding of pSTAT3- 
Tyr705 to the AHSP promoter and augments AHSP expres-
sion in K562 cells, meanwhile, AHSP levels were reduced 
in STAT3-siRNA K562 cells. Moreover, a concomitant 
increase of AHSP as well as STAT3 transcription was ob-
served in α-globin-overloaded K562 cells. Together, these 
observations propose AHSP as a new target of STAT3 sig-
naling for orchestrating cellular homeostasis under stress 
conditions during erythropoiesis. AHSP gene expression 
was previously reported to increase parallel to α-globin 
during maturation of erythroid cells [30]. The potential in-
volvement of STAT3 remains an intriguing issue to be in-
vestigated in primary erythroid cultures or during embryon-
ic hematopoiesis.   
Multiple STAT3 binding sites were identified in the 
AHSP promoter. Although STAT3 knock-down K562 cells 
showed decreased AHSP expression, the binding of STAT3 
in unchallenged K562 cell was weak. Remarkable STAT3 
binding was observed after the stimulation by IL-6 or 
overwhelming free α-globin, indicating those sites as pre-
dominantly stress-responsive elements. In addition, pSTAT3- 
Tyr705, but not pSTAT3-Ser727 signals, were detected in 
both IL-6 treated and α-globin-overloaded K562 cells, sug-
gesting divergent functions of these two active STAT3 
modifications. The observations are consistent with a pre-
vious study which claims that p-STAT3-Tyr705 is neces-
sary for STAT3 activation, while p-STAT3-Ser727 may be 
asscociated with stronger transactivation [31].   
We show that the STAT3 binding site at SB3 is one of 
the major STAT3 responsive elements in the AHSP pro-
moter. In addition, the SB3 site contains an atypical 
Nrf2/ARE element intimately connected with the STAT3 
site. In addition to the binding of STAT3, EMSA analysis 
also showed the in vitro binding ability of Nrf2 to SB3. 
Nrf2 is the central mediator of ROS signaling [32] and has 
been shown important for maintaining redox balance in 
hemolyte anemia [33]. Nrf2 also regulates heme synthesis, 
iron transportation and globin gene expression in erythroid 
cells [34,35]. We found in this work that the Nrf2 activator 
tBHQ-treated K562 cells nuclear extract displayed apparent 
increased STAT3-binding to the SB3 site in EMSA. This 
observation is consistent with the previous study showing 
that Nrf2 controls the expression of IL-6, which is upstream 
of STAT3 signaling [36]. Alternatively, this might indicate 
a potential synergy between Nrf2 and STAT3 when recruit-
ing to target sites in the AHSP promoter. Further investiga-
tion of the Nrf2/ARE pathway is therefore necessary for 
corroborating this promising new candidate in AHSP gene 
regulation and teasing out the potential cross-talk between 
Nrf2 and STAT3 in AHSP regulation. Furthermore, how the 
anti-oxidative response elements, such as the SB3 site iden-
tified in this study, may cooperate with the erythroid spe-
cific cis-elements [37] in coordinating AHSP expression 
remains an intriguing issue to be investigated in thalassemia 
cells.  
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